Welcome to our dedicated page for Angi SEC filings (Ticker: ANGI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Angi Inc. (NASDAQ: ANGI), a home services platform in the Information sector. Here, investors can review the company’s official regulatory documents and use AI-powered tools to understand the key points in each filing.
Angi’s SEC filings include periodic reports such as annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its business, risk factors and financial condition. Current reports on Form 8-K disclose specific events, including quarterly earnings announcements and material agreements. For example, an 8-K dated November 6, 2025, details a senior secured revolving credit facility entered into by ANGI Group, LLC, outlining the size of the facility, collateral, guarantees, covenants and intended uses of proceeds.
Other 8-K filings referenced in 2025 describe the release of quarterly results and the posting of earnings press releases and shareholder letters on Angi’s investor relations website, furnished under items related to results of operations and Regulation FD disclosure. An 8-K dated June 17, 2025, reports the results of Angi’s annual meeting of stockholders, including the election of directors and ratification of the company’s independent registered public accounting firm.
On this page, users can also find information related to proxy statements, which cover matters such as director elections and auditor ratification, and may access filings related to executive and board actions. AI-generated summaries highlight important terms, covenants and events in forms such as 10-K, 10-Q and 8-K, and help explain how credit agreements, leverage tests and other provisions described in the filings relate to Angi’s operations and capital structure.
Kris Boon, Chief Product Officer of Angi Inc. (ANGI), received a grant of 72,500 restricted stock units on 09/17/2025 that convert to Class A common shares upon vesting. The award is reported as direct ownership of 72,500 shares following the grant. The RSUs vest in three installments: approximately 21% on March 1, 2027, 21% on March 1, 2028, and 59% on March 1, 2029, subject to continued service. The Form 4 was signed by an attorney-in-fact on 09/18/2025. Each RSU represents a contingent right to one share of Class A common stock.
Glenn Orchard, Chief Growth Officer of Angi Inc. (ANGI), was granted 35,666 restricted stock units on 09/17/2025. Each unit represents a contingent right to receive one share of Class A common stock, and the award is recorded as directly beneficially owned at 35,666 shares following the grant. The RSUs vest in three tranches: approximately 16% on March 1, 2027, 16% on March 1, 2028, and 68% on March 1, 2029, subject to continued service, so the award will be fully vested on March 1, 2029. The Form 4 was filed by a single reporting person and signed by an attorney-in-fact on 09/18/2025.
Angi Inc. Chief Operating Officer Carson Bailey was granted 37,500 restricted stock units (RSUs) on 09/17/2025, each representing the right to receive one share of Class A common stock. The award vests in three installments: 20% on March 1, 2027, 20% on March 1, 2028, and 60% on March 1, 2029, subject to continued service. Following the reported transaction, Mr. Bailey beneficially owns 37,500 shares on a direct basis as reported. The Form 4 was signed by Shannon M. Shaw as attorney-in-fact on 09/18/2025.
Shannon Shaw, Chief Legal Officer of Angi Inc. (ANGI), received a grant of 27,084 restricted stock units (RSUs) on 09/17/2025. Each RSU represents the right to one share of Class A common stock and will convert to shares upon vesting. The award vests in three tranches: approximately 29% on March 1, 2027, 29% on March 1, 2028, and 42% on March 1, 2029, contingent on continued service. Following the grant, Ms. Shaw beneficially owns 27,084 shares of Class A common stock on a direct basis. The RSUs have no exercise price and are reported as derivative securities tied to underlying common stock.
Angi Inc. insider award reported: A director received 13,500 restricted stock units (RSUs) that each convert into one share of Class A common stock. The award vests in three installments—approximately 15%, 30% and 56%—on successive annual vesting dates beginning in 2027, and is scheduled to be fully vested by 2029, subject to continued service. The transaction was recorded as an acquisition and the reporting form was submitted by a single reporting person.
Angi Inc. (ANGI) reported a grant of 55,834 restricted stock units to Andrew Russakoff, the company's Chief Financial Officer, in a transaction dated 09/17/2025. Each unit represents a contingent right to one share of Class A Common Stock and the award carries a $0 purchase price.
The award vests in three installments: approximately 7% on March 1, 2027, 43% on March 1, 2028 and 49% on March 1, 2029, subject to continued service, so the award will be fully vested on March 1, 2029.
Shannon Shaw, Chief Legal Officer of Angi Inc. (ANGI), reported insider transactions on 09/02/2025. On that date 3,554 restricted stock units vested and converted one-for-one into Class A common shares, increasing her beneficial ownership to 56,643 shares. The filing also shows a sale of 1,044 shares at $17.56 each, leaving 55,599 shares beneficially owned after the reported transactions. The RSUs were part of a 142,180-unit grant (pre-reverse split) that vests in four equal annual installments beginning one year after grant. The report is a routine Section 16 disclosure reflecting scheduled vesting and a market sale.
Thomas C. Pickett Jr., a director of Angi Inc. (ANGI), reported receipt of 3,577 shares on 08/22/2025 arising from restricted stock units that convert one-for-one into Class A common stock. After this transaction Pickett beneficiallyowned 7,153 shares directly. The filing notes the RSUs were originally granted on 08/22/2023 (107,296 units on a pre-reverse-split basis) and vest in three equal annual installments beginning one year after grant. The report was signed by an attorney-in-fact on behalf of Pickett on 08/25/2025.
Angi Inc. received a joint Schedule 13G/A disclosing that HighSage Ventures LLC and Jennifer Stier beneficially own Class A Common Stock. HighSage Ventures reports 2,530,134 shares (representing 5.6% of the class) while Jennifer Stier reports 3,030,250 shares (6.7% of the class), based on 45,131,000 Class A shares outstanding as of June 30, 2025. The filing states the shares are held through certain limited liability companies managed by HighSage or Stier, that the Reporting Persons filed a Joint Filing Agreement, and that the holdings were not acquired to change or influence control of the issuer.